Cargando…
Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
BACKGROUND: In Ethiopia, case fatality rates among subgroups of visceral leishmaniasis (VL) patients are high. A clinical prognostic score for death in VL patients could contribute to optimal management and reduction of these case fatality rates. We aimed to identify predictors of death from VL, and...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459471/ https://www.ncbi.nlm.nih.gov/pubmed/28582440 http://dx.doi.org/10.1371/journal.pone.0178996 |
_version_ | 1783241972981432320 |
---|---|
author | Abongomera, Charles Ritmeijer, Koert Vogt, Florian Buyze, Jozefien Mekonnen, Zelalem Admassu, Henok Colebunders, Robert Mohammed, Rezika Lynen, Lutgarde Diro, Ermias van Griensven, Johan |
author_facet | Abongomera, Charles Ritmeijer, Koert Vogt, Florian Buyze, Jozefien Mekonnen, Zelalem Admassu, Henok Colebunders, Robert Mohammed, Rezika Lynen, Lutgarde Diro, Ermias van Griensven, Johan |
author_sort | Abongomera, Charles |
collection | PubMed |
description | BACKGROUND: In Ethiopia, case fatality rates among subgroups of visceral leishmaniasis (VL) patients are high. A clinical prognostic score for death in VL patients could contribute to optimal management and reduction of these case fatality rates. We aimed to identify predictors of death from VL, and to develop and externally validate a clinical prognostic score for death in VL patients, in a high HIV co-infection burden area in Ethiopia. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a retrospective cohort study in north west Ethiopia. Predictors with an adjusted likelihood ratio ≥1.5 or ≤0.67 were retained to calculate the predictor score. The derivation cohort consisted of 1686 VL patients treated at an upgraded health center and the external validation cohort consisted of 404 VL patients treated in hospital. There were 99 deaths in the derivation cohort and 53 deaths in the external validation cohort. The predictors of death were: age >40 years (score +1); HIV seropositive (score +1); HIV seronegative (score -1); hemoglobin ≤6.5 g/dl (score +1); bleeding (score +1); jaundice (score +1); edema (score +1); ascites (score +2) and tuberculosis (score +1). The total predictor score per patient ranged from -1 to +5. A score of -1, indicated a low risk of death (1.0%), a score of 0 an intermediate risk of death (3.8%) and a score of +1 to +5, a high risk of death (10.4–85.7%). The area under the receiver operating characteristic curve was 0.83 (95% confidence interval: 0.79–0.87) in derivation, and 0.78 (95% confidence interval: 0.72–0.83) in external validation. CONCLUSIONS/SIGNIFICANCE: The overall performance of the score was good. The score can enable the early detection of VL cases at high risk of death, which can inform operational, clinical management guidelines, and VL program management. Implementation of focused strategies could contribute to optimal management and reduction of the case fatality rates. |
format | Online Article Text |
id | pubmed-5459471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-54594712017-06-15 Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia Abongomera, Charles Ritmeijer, Koert Vogt, Florian Buyze, Jozefien Mekonnen, Zelalem Admassu, Henok Colebunders, Robert Mohammed, Rezika Lynen, Lutgarde Diro, Ermias van Griensven, Johan PLoS One Research Article BACKGROUND: In Ethiopia, case fatality rates among subgroups of visceral leishmaniasis (VL) patients are high. A clinical prognostic score for death in VL patients could contribute to optimal management and reduction of these case fatality rates. We aimed to identify predictors of death from VL, and to develop and externally validate a clinical prognostic score for death in VL patients, in a high HIV co-infection burden area in Ethiopia. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a retrospective cohort study in north west Ethiopia. Predictors with an adjusted likelihood ratio ≥1.5 or ≤0.67 were retained to calculate the predictor score. The derivation cohort consisted of 1686 VL patients treated at an upgraded health center and the external validation cohort consisted of 404 VL patients treated in hospital. There were 99 deaths in the derivation cohort and 53 deaths in the external validation cohort. The predictors of death were: age >40 years (score +1); HIV seropositive (score +1); HIV seronegative (score -1); hemoglobin ≤6.5 g/dl (score +1); bleeding (score +1); jaundice (score +1); edema (score +1); ascites (score +2) and tuberculosis (score +1). The total predictor score per patient ranged from -1 to +5. A score of -1, indicated a low risk of death (1.0%), a score of 0 an intermediate risk of death (3.8%) and a score of +1 to +5, a high risk of death (10.4–85.7%). The area under the receiver operating characteristic curve was 0.83 (95% confidence interval: 0.79–0.87) in derivation, and 0.78 (95% confidence interval: 0.72–0.83) in external validation. CONCLUSIONS/SIGNIFICANCE: The overall performance of the score was good. The score can enable the early detection of VL cases at high risk of death, which can inform operational, clinical management guidelines, and VL program management. Implementation of focused strategies could contribute to optimal management and reduction of the case fatality rates. Public Library of Science 2017-06-05 /pmc/articles/PMC5459471/ /pubmed/28582440 http://dx.doi.org/10.1371/journal.pone.0178996 Text en © 2017 Abongomera et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Abongomera, Charles Ritmeijer, Koert Vogt, Florian Buyze, Jozefien Mekonnen, Zelalem Admassu, Henok Colebunders, Robert Mohammed, Rezika Lynen, Lutgarde Diro, Ermias van Griensven, Johan Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia |
title | Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia |
title_full | Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia |
title_fullStr | Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia |
title_full_unstemmed | Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia |
title_short | Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia |
title_sort | development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high hiv co-infection burden area in ethiopia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459471/ https://www.ncbi.nlm.nih.gov/pubmed/28582440 http://dx.doi.org/10.1371/journal.pone.0178996 |
work_keys_str_mv | AT abongomeracharles developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT ritmeijerkoert developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT vogtflorian developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT buyzejozefien developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT mekonnenzelalem developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT admassuhenok developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT colebundersrobert developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT mohammedrezika developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT lynenlutgarde developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT diroermias developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia AT vangriensvenjohan developmentandexternalvalidationofaclinicalprognosticscorefordeathinvisceralleishmaniasispatientsinahighhivcoinfectionburdenareainethiopia |